Congratulations to Dr. Deborah Stephens on her recently accepted manuscript in the Journal of Clinical Oncology. The study entitled, " Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736" reported on a two decade follow up by the SWOG Lymphoma Working Group on risk assessment of 400 patients with diffuse large B-cell lymphoma. The group reported that relapse occurred independent of the treatment modality. This highlights the importance of long-term followup studies to assess treatment efficacy.